PureTech Health plc
PureTech Health plc (PRTC) Revenue
Annual & quarterly revenue history · segment & region breakdown
PRTC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPureTech Health plc trailing twelve-month (TTM) revenue is $0.01B, a decrease of 3.50% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -3.50% |
| 2024-12-31 | $0.00B | +$0.00B | +44.98% |
| 2023-12-31 | $0.00B | +$0.00B | +59.33% |
| 2022-12-31 | $0.00B | -$0.01B | -79.06% |
| 2021-12-31 | $0.01B | +$0.00B | +19.64% |
| 2020-12-31 | $0.01B | -$0.00B | -3.99% |
| 2019-12-31 | $0.01B | -$0.01B | -46.93% |
| 2018-12-31 | $0.02B | +$0.02B | +2418.62% |
| 2017-12-31 | $0.00B | -$0.00B | -85.33% |
| 2016-12-31 | $0.00B | -$0.01B | -62.26% |
Compare revenue vs peers
BiotechnologyCompare PRTC revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income PureTech Health plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
PureTech Health plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from PureTech Health plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PRTC revenue · 4 questionsPRTC's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 3.50% year-over-year from $0.00B in FY2025.
▸ Source: FMP · PureTech Health plc SEC filings · GAAP · PureTech Health plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026